Making cybersecurity part of your company’s DNA
What are the questions you need to ask about your private equity investments to determine how much cybersecurity is “enough?”
Private equity as a force for ESG value-creation
For Adam Blumenthal, founder of private equity firm Blue Wolf Capital Partners, ESG investing is part of his firm’s DNA. Watch to learn.
Q1 2021 Dealmaker Roundup
Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.
A Powerhouse in Private Equity
Listen to Peleton Capital Management’s co-founder Steve Faraone share insights on a wide-range of topics including investing in a pandemic.
The Changing Investor Landscape Under COVID-19
While 2021 may turn into a feeding frenzy for private equity, longer-term investors can remain as selective as they’ve always been.
Cost-effective approach to an integration for a smaller transaction
Outsourcing integration management led to measurable impact for a PE-owned SaaS provider to the long-term care market
Cyber due diligence: A must regardless of environment
If a security breach occurs during the holding period, it jeopardizes the overall investment objectives, hence the need for cyber diligence.
When deals stall: Turning transaction costs into cash flow
Many deals stalled as the pandemic began, prompting investors to look at turning transaction costs into cash flow—but beware of pitfalls.
Key considerations for private equity in managing the COVID-19 crisis
Read insights from the PE community on managing portfolio company cash flow, assessing operational threats and planning the next M&A move.
How to prepare for a first year audit after acquisition
Audit readiness shouldn’t be an afterthought of an acquisition. Being well prepared minimizes financial risks to your private equity firm.